v3.25.2
SHARE-BASED COMPENSATION (Tables)
 6 Months Ended
Jun. 30, 2025
Equity [Abstract]  
Schedule of Stock Option Issuances and Balances Outstanding
The following table summarizes stock option activity during the six months ended June 30, 2025:
 Shares Underlying OptionsWeighted Average Exercise PriceWeighted Average Remaining Contractual Life (years)Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 20249,283,331 $20.13 5.51$16,408 
Granted1,434,200 20.50
Exercised(289,106)16.54 1,577 
Forfeited/canceled(242,094)23.65
Outstanding at June 30, 202510,186,331 $20.20 6.05$9,485 
Vested and expected to vest at June 30, 202510,186,331 $20.20 5.82$9,485 
Exercisable at June 30, 20257,341,431 $21.15 4.91$4,534 
Schedule of Service Based Restricted Stock Activity
The following table summarizes the Company’s service based restricted stock unit activity during the six months ended June 30, 2025:
 Number of Restricted Stock UnitsWeighted Average Grant Date Fair Value
Unvested at December 31, 20243,517,263 $15.41 
Granted2,180,790 20.15 
Vested(1,169,451)16.29 
Forfeited/canceled(121,553)16.31 
Unvested at June 30, 20254,407,049 $17.49 
Schedule of Performance Based Restricted Stock Activity
The following table summarizes the Company’s performance based restricted stock unit activity during the six months ended June 30, 2025:
 Number of Restricted Stock UnitsWeighted Average Grant Date Fair Value
Unvested at December 31, 2024216,208 $18.34 
Granted88,000 20.46 
Vested(70,604)27.54 
Forfeited/canceled— — 
Unvested at June 30, 2025233,604 $16.35 
Schedule of Share Based Compensation Expenses The following table sets forth share-based compensation for continuing operations for the three and six months ended June 30, 2025 and 2024 (in thousands):
 Three Months Ended June 30,Six Months Ended June 30,
 2025202420252024
Research and development$3,990 $3,774 $8,716 $7,431 
Selling, general and administrative6,659 6,146 13,425 12,246 
Total share-based compensation$10,649 $9,920 $22,141 $19,677